Opportunities and challenges in renaming non-alcoholic fatty liver disease as metabolic dysfunction-associated steatotic liver disease
10.3760/cma.j.cn101070-20241031-00705
- VernacularTitle:儿童非酒精性脂肪性肝病更名为代谢相关脂肪性肝病的机遇与挑战
- Author:
Sitian KE
1
;
Hui WANG
;
Junfen FU
Author Information
1. 浙江大学医学院附属儿童医院内分泌科，国家儿童健康与疾病临床医学研究中心，杭州 310052
- Publication Type:Journal Article
- Keywords:
Child;
Non-alcoholic fatty liver disease;
Metabolic dysfunction-associated fatty liver disease/ metabolic dysfunction-associated steatotic liver disease
- From:
Chinese Journal of Applied Clinical Pediatrics
2025;40(10):787-791
- CountryChina
- Language:Chinese
-
Abstract:
Non-alcoholic fatty liver disease (NAFLD) has emerged as one of the most prevalent chronic liver diseases worldwide, with its nomenclature undergoing several stages of evolution.The three major term transitions from NAFLD to metabolic dysfunction-associated fatty liver disease (MAFLD) and subsequently metabolic dysfunction-associated steatotic liver disease (MASLD) have attracted extensive attention and discussion, presenting unprecedented opportunities and challenges.In this article, the historical development of terminology in the field of pediatric fatty liver disease was reviewed and a comparative analysis of the three primary terms (NAFLD, MAFLD, and MASLD) was conducted.By an exploration of these term changes and their implications for clinical practice, this review aims to offer valuable insights for researchers and clinicians.
